学龄前症状前1型糖尿病儿童的纵向持续葡萄糖监测研究
该研究基于澳大利亚ENDIA队列,对36名持续多胰岛自身抗体阳性的儿童每3-6个月进行盲法持续葡萄糖监测(CGM),共分析178次评估。结果显示CGM指标在个体内高度变异,包括血糖>7.8 mmol/L时间百分比(组内相关系数0.30),提示需进一步研究以指导症状前1型糖尿病儿童CGM指标解读。
要点
- 症状前1型糖尿病幼儿的CGM指标个体内变异大,需谨慎解读单次结果。
- 血糖>7.8 mmol/L时间百分比的组内相关系数仅0.30,重复性有限。
- 目前尚需更多研究来指导该人群CGM指标的临床解释。
核心结论
- 症状前1型糖尿病幼儿的纵向CGM指标存在高度个体内变异,需进一步研究以指导解读。
研究设计与样本
- 2021至2024年澳大利亚ENDIA研究中持续多胰岛自身抗体阳性的儿童,每3-6个月接受盲法CGM评估。
- 共纳入36名儿童,首次评估中位年龄4.5岁,分析178次CGM评估。
主要发现
- 每名儿童中位接受5.5次CGM评估,每次中位持续时间11天。
- CGM指标包括血糖标准差、变异系数、平均血糖及血糖>7.8 mmol/L时间百分比,个体内变异高。
- 血糖>7.8 mmol/L时间百分比的组内相关系数为0.30。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize longitudinal continuous glucose monitoring (CGM) data in young children with presymptomatic type 1 diabetes. RESEARCH DESIGN AND METHODS: Between 2021 and 2024, children in the Australian ENDIA study with persistent multiple islet autoimmunity underwent blinded CGM assessments every 3-6 months. CGM-derived metrics (SD sensor glucose, coefficient of variation, mean sensor glucose, and percent CGM time >7.8 mmol/L [140 mg/dL]) were determined for each child by time from islet autoantibody detection. RESULTS: A total of 178 CGM assessments were analyzed for 36 children (median [Q1, Q3] age at first assessment 4.5 [3.5, 6.0] years) who underwent a median of 5.5 (2.0, 7.0) assessments of 11 (9, 15) days duration each. High within-person variability was observed in serial CGM metrics, including percent CGM time >7.8 mmol/L (140 mg/dL) (intraclass correlation coefficient 0.30). CONCLUSIONS: Further research is needed to inform interpretation of CGM-derived metrics in young children with presymptomatic type 1 diabetes.
引用
- Haynes A, Smith GJ, Tully A, et al. Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study. Diabetes Care. 2025. PMID: 40828811. doi:10.2337/dc25-0821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。